1. |
Spurzem JR,Rennard SI.Pathogenesis of COPD.Semin Respir Crit Care Med,2005,26:142-153.
|
2. |
Jørgensen NR,Schwarz P,Holme I,et al.The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease:a cross sectional study.Respir Med,2007,101:177-185.
|
3. |
中華醫學會呼吸病學分會慢性阻塞性肺疾病學組.慢性阻塞性肺疾病診治指南.中華內科雜志,2002,41:640-646.
|
4. |
Bolton CE,Ionescu AA,Shiels KM,et al.Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2004,170:1286-1293.
|
5. |
Balasubramanian VP,Varkey B.Chronic obstructive pulmonary disease:effects beyond the lungs.Curr Opin Pulm Med,2006,12:106-112.
|
6. |
Papaioannou A,Parkinson W,Ferko N,et al.Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada.Osteoporos Int,2003,14:913-917.
|
7. |
李斯南.43例慢性阻塞性肺病患者骨密度和骨代謝的改變.醫藥論壇雜志,2003,24:27-28.
|
8. |
郭素華,楊定焯,許志奇,等.從慢性支氣管炎的骨密度改變論久咳傷腎.華西醫學, 1992, 7:46-47.
|
9. |
辛洪濤,侯林江,孔祥輝. 慢性阻塞性肺病鈣磷調節激素與骨礦含量的研究.實用中西醫結合雜志,1998,11:577-579.
|
10. |
Kumeda Y,Lnaba M,Nishizawa Y.Secondary osteporosis and its treatment--diabetes mellitus.Nippon Rinsho,1998,56:1579-1586.
|
11. |
Sin DD,Man JP,Man SF.The risk of osteoporosis in Caucasian men and women with obstructive airways disease.Am J Med,2003,114:10-14.
|
12. |
Wouters EF,Creutzberg EC,Schols AM.Systemic effects in COPD.Chest,2002,121:127S-130S.
|
13. |
Varkey AB.Chronic obstructive pulmonary disease in women:exploring gender differences.Curr Opin in Pulm Med,2004,10:98-103.
|
14. |
Katsura H,Kida K.A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma.Chest,2002,122:1949-1955.
|
15. |
Tschopp O,Boehler A,Speich R,et al.Osteoporosis before lung transplantation:association with low body mass index,but not with underlying disease.Am J Transplant,2002,2:167-172.
|
16. |
Gan WQ,Man SF,Senthilselvan A,et al.Association between chronic obstructive pulmonary disease and systemic inflammation:a systematic review and a meta-analysis.Thorax,2004,59:574-580.
|
17. |
Eid AA,Ionescu AA,Nixon LS,et al.Inflammatory response and body composition in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2001,164:1414-1418.
|
18. |
李衛,苗懿德.老年男性慢性阻塞性肺疾病患者骨代謝的研究.中國骨質疏松雜志,2005,11:221-224.
|
19. |
凌萬軍,葛春方.煙酒對骨密度的影響.中華預防醫學雜志,1999,33:63.
|
20. |
Shane E,Silverberg SJ,Donovan D,et al.Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.Am J Med,1996,101:262-269.
|
21. |
Seeman E.The effects of tobacoo and alconol use on bone.In:Marcus R,Feldman D,Kelsey J,eds.Osteoporosis.Osteoporosis.San Diego:Academic Press,1996,577-597.
|
22. |
Gan WQ,Man SF,Sin DD.Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease:a systematic review and a meta-analysis.BMC Pulm Med,2005,5:3.
|
23. |
Sin DD,Wu L,Anderson JA,et al.Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.Thorax,2005,60:992-997.
|
24. |
Lung Health Study Research Group.Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease.N Engl J Med,2000,343:1902-1909.
|
25. |
Scanlon PD,Connett JE,Wise RA,et al.Loss of bone density with inhaled triamcinolone in Lung Health Study II.Am J Respir Crit Care Med,2004;170:1302-1309.
|
26. |
Canalis E.Clinical review 83:Mechanisms of glucocorticoid action in bone:implications to glucocorticoid-induced osteoporosis.J Clin Endocrinol Metab,1996,81:3441-3447.
|
27. |
Adachi JD.Corticosteroid-induced osteoporosis.Am J Med Sci,1997,313:41-49.
|
28. |
Lane NE,Lukert B.The science and therapy of glucocorticoid-induced bone loss.Endocrinol Metab Clin North Am,1998,27:465-483.
|